✦ LIBER ✦

Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FU

✍ Scribed by T.J. Iveson; T. Hickish; C. Schmitt; E. Van Cutsem

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCA2: IRINOTECAN IN FIRST LINE TREATMENT

✍ DL Jackson; A Burrell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN70 MODELLING THE COST EFFECTIVENESS O

✍ C Holmberg; R Aultman; U Siebert; E Sabate; M Gyldmark 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Multicenter phase II study of irinotecan

✍ Schöffski, P.; Vanhoefer, U.; Kirchner, H.; Trenn, G.; Bokemeyer, C.; Preusser, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase II study of irinotecan with bolus

✍ Leonard, P; Seymour, M T; James, R; Hochhauser, D; Ledermann, J A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

Irinotecan (Iri) in combination with hig

✍ P. Rougier; D. Cunningham; A.D. Roth; J.R. Germa; R.D. James; P. Karasek; P. Jan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Combining bevacizumab and panitumumab wi

✍ Liang, Hong-Liang; Hu, Ai-Ping; Li, Sen-Lin; Liu, Ji-Yong 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 195 KB